This expert group consensus statement emphasises the need for standardising the definition
of progressive fibrosing interstitial lung diseases (F-ILDs), with an accurate initial diagnosis …

Lung development starts in utero and continues during childhood through to adolescence,
reaching its peak in early adulthood. This growth is followed by gradual decline due to …

Rationale: Criteria for progressive pulmonary fibrosis (PPF) have been proposed, but their
prognostic value beyond categorical decline in FVC remains unclear. Objectives: To …

Interstitial lung disease (ILD) is a diverse group of inflammatory and fibrotic lung conditions
causing significant morbidity and mortality. A multitude of factors beyond the lungs influence …

Interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) have an array
of immunomodulatory treatment options compared with IPF, due to their inflammatory …

Importance Interstitial lung disease (ILD) consists of a group of pulmonary disorders
characterized by inflammation and/or fibrosis of the lung parenchyma associated with …

Background A genomic classifier for usual interstitial pneumonia (gUIP) has been shown to
predict histological UIP with high specificity, increasing diagnostic confidence for idiopathic …

The last 2 years have presented previously unforeseen challenges in pulmonary medicine.
Despite the significant impact of the SARS‐CoV‐2 pandemic on patients, clinicians and …

Background: Limited data are available regarding the entire spectrum of interstitial lung
disease with a progressive fibrosing feature. We investigated the prevalence and prognostic …

Abstract Background and Objective The identification of progression in patients with
fibrosing non‐idiopathic pulmonary fibrosis (IPF) interstitial lung diseases (ILDs) represents …